Internet

To WebMD or not to WebMD?

screenshot_193POST SUMMARY: WebMD is the number one health portal on the Internet, but is it really required to consider WebMD as part of pharma marketers online media plans?  Not really. Continue reading »

What frustrates online health seekers on pharma websites?

UnknownPOST SUMMARY: While your web analytics might indicate that you are getting a lot of traffic to your product website upstream and downstream analysis indicates that visitors are also going to other health websites to both fact check your claims and help them better understand complicated health language. Continue reading »

Time to ditch ROI discussions for DTC Marketing

ditchroiPOST SUMMARY: It’s hard to have a meeting to discuss new DTC marketing initiatives without the dreaded ROI discussion. I understand that the current business environment in biopharma is about creating customers, but the problem is that consumers today don’t want to be sold.  If you really want to closer to your customers, find ways to help them make better healthcare decisions and get good credible health information. Continue reading »

Physicians and social media

docssocmed64% of physicians use at least one of the types of social network while 36% do not use any, according to the Sources & Interactions Study, September 2013. This breaks down to 13% of doctors using all three types, 25% using 2 of the 3, and 26% using only 1 of the 3 types.

screenshot_94

 

Continue reading »

Content and innovation for pharma marketers

Bright IdeaPOST SUMMARY: If you want to excel as an innovator in the future, don’t set out to copy and improve what someone else has already done. Focus on your audience and deliver a great online brand experience while answering their concerns about living with health conditions. Continue reading »

Time to rethink pharma reps?

docrepsPOST SUMMARY: 32% of physicians said they cannot talk to reps, compared to 27% last year. Apply this limit to doctors in organized health systems, and the restrictions become even greater: 42% of doctors affiliated with integrated health networks say they are not allowed to see reps—a 17% increase since last year.  Time for pharma to rethink reps? Continue reading »

Share with your friends










Submit